Richter earnings exceed expectations
Image by Richter.hu
Listed pharmaceutical Gedeon Richter beats analyst expectations on ample second-quarter revenue and earnings, according to business daily Világgazdaság.
According to the VG consensus, analysts expected revenue of HUF 143.5 billion, while the pharmaceutical company achieved HUF 155.9 bln, 13.6% more than in the reference period. The gross margin was 56.6%.
The group spent HUF 27.7 bln on pharmaceutical marketing, 12.6% more than a year ago, and research and development expenses increased by a similar amount to HUF 16 bln. Based on all this, the operating profit also improved considerably, increasing by 34% to HUF 36.4 bln, although the experts expected it to be HUF 28.2 bln.
Seeing the development of foreign exchange effects, it could be enveloped that the second quarter could be unprofitable in terms of finances, minus HUF 6.1 billion in the end.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.